Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc. (HIMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Hims & Hers Health (HIMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HIMS vs. TDOC: Which Digital Health Stock Offers Better Upside Now?
Hims & Hers and Teladoc Health are taking different paths in digital health, but which stock offers stronger upside now? Let's dive in.
Hims & Hers Health, Inc. (HIMS) is a Top-Ranked Momentum Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors
The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $29.39, representing a -3.83% change from its previous close.
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
JPMorgan Initiates Hims & Hers With Overweight: Could the Novo Nordisk Deal Be the Turning Point?
Hims & Hers Health (NYSE:HIMS) just picked up a high-profile endorsement.
Why Hims & Hers Health, Inc. (HIMS) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Hims & Hers expands into menopause care as estrogen patch demand rises
Telehealth company Hims & Hers said on Wednesday it will now offer treatment options for perimenopause and menopause via its platform, as rising U.S. demand for hormone therapy strains supplies of estrogen patches.
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors
Hims & Hers Health, Inc. (HIMS) reached $29.76 at the closing of the latest trading day, reflecting a -4.03% change compared to its last close.
Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program
Expand NYSE: HIMS Hims & Hers Health Today's Change (-3.89%) $-1.21 Current Price $29.80 Key Data Points Market Cap $7.1B Day's Range $27.90 - $30.86 52wk Range $13.74 - $70.43 Volume 2.1M Avg Vol 38M Gross Margin 60.86% Hims & Hers Health (HIMS 3.89%), the consumer-focused telehealth platform, closed Tuesday at $29.76, down 4.03%. The stock declined during the regular session after Amazon (AMZN +0.63%) launched a competing GLP-1 weight-loss program, though it has still gained 39.33% in the past week.
Hims & Hers Builds Scalable Data-Driven Personalized Care Platform
HIMS is building a data-driven care platform, adding Labs and multi-cancer testing to personalize treatment via continuous monitoring insights.
Hims & Hers Rallies 9% as Investors Bet Big on Peptide Pipeline and Novo Nordisk Deal
Hims & Hers Health (NYSE:HIMS) shares are up 9% in early trading Monday, climbing from $28.82 to $31 and change as investors pile into the stock ahead of a May 11 earnings report.
